Navigation Links
Global Pharmaceutical Survey 2012-2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry
Date:5/15/2012

NEW YORK, May 15, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

 

Global Pharmaceutical Survey 2012–2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry

http://www.reportlinker.com/p0795163/Global-Pharmaceutical-Survey-2012–2013-Market-Trends-Marketing-Spend-and-Sales-Strategies-in-the-Global-Pharmaceutical-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Marketing

 

Synopsis

 

• This report is the result of an extensive survey drawn from ICD Research's exclusive panel of leading pharmaceutical industry executives. The opinions and forward looking statements of 247 industry executives have been captured in our in-depth survey.

 

• The research is based on primary survey research conducted by ICD Research accessing its B2B panels comprised of senior marketing decision makers and leading supplier organizations.

 

• The geographical scope of the research is global - drawing on the activity and expectations of leading industry players across the Americas, Europe, Asia-Pacific and Africa and Middle East.

 

• The report covers data and analysis on suppliers' media budgets, marketing and sales strategies and business practices.

 

• Key topics covered include pharmaceutical industry media spend activity, marketing and sales behaviors and strategies by suppliers, as well as threats and opportunities, economic outlook and business confidence.

 

• In the report, buyers identify what suppliers need to do to maintain their business and the key actions being taken by industry players to overcome the leading business threats.

 

• The report examines current practices and provides future expectations over the next 12–24 months.

 

• The report provides qualitative analysis of the key industry threats and opportunities and contains full survey results.

 

Summary

 

"Global Pharmaceutical Survey 2012–2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry" is a new report by ICD Research that analyzes how Pharmaceutical industry suppliers' media spend, marketing and sales strategies and business practices are set to change 2012–2013. This report gives you access to the media channel spending outlooks, media budgets, marketing agency selection criteria, business challenges and sales tactics of leading suppliers. The report also identifies future growth of buyers and suppliers, M&A and investment expectations. This report not only grants access to the opinions and strategies of business decision makers and competitors, but also examines their actions surrounding business priorities. The report also provides access to information categorized by region, company type and sizes.

 

Scope

 

The report features the opinions of global Pharmaceutical industry respondents related to the following:

 

• Revenue growth and future developments in business structure.

• Merger and acquisition activity.

• Capital expenditure and change in staff recruitment activity.

• Key regions of growth.

• Key industry threats and opportunities.

• Annual marketing budgets and change in marketing expenditure.

• Future spending outlook on media channels.

• Marketing agency selection criteria.

 

Reasons To Buy

 

Why was the report written?

This report is the result of an extensive survey drawn from ICD Research's exclusive panel of 247 leading global pharmaceutical industry executives. The report provides data and analysis on global pharmaceutical industry suppliers' media spend, marketing and sales strategies, and practices and business planning within the global pharmaceutical industry. This report includes key topics such as media channel spending outlooks, media budgets, marketing agency selection criteria, business challenges and sales tactics of leading suppliers within global pharmaceutical industry. The report also identifies pharmaceutical manufacturers, contract research and contract manufacturing companies' and suppliers' future growth, M&A and investment expectations.

Most secondary research reports are based on general industry drivers and do not understand the industry executives' attitude and changing behaviours, creating a gap in presenting the business outlook of the industry. In an effort to bridge this gap, ICD Research created this primary-research based report by gathering the opinions of multiple stake holders in the value-chain of the global pharmaceutical industry.

 

What is the current market landscape and what is changing?

The top three key expected changes in business structure for 2011 are the addition of 'new products and service' portfolios, 'improvement of operational efficiency', and 'expansion in current markets'. As major drugs are set to lose patent rights in the short term, companies have increased the pace of new product development. For example, Johnson & Johnson expect to file 11 new products and 30 product line extensions in 2011–2015. With the launch of these new products, the company expects to increase its market share and geographical reach.

 

What are the key drivers behind recent market changes?

Executives from the pharmaceutical industry expect to see increased levels of consolidation with 68% of respondents predicting that there will be either a 'significant increase' or 'increase' in M&A activity over the next 12 months. The need for new product pipelines, new product acquisitions, patent expiries, cost containment and credit availability are considered as the major drivers for this expected increase in M&A activity in the pharmaceutical manufacturing industry.

 

What makes this report unique and essential to read?

"Global Pharmaceutical Survey 2012–2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry" is a new report by ICD Research that analyzes how Pharmaceutical industry companies' media spend, marketing and sales strategies & practices and business planning are set to change in 2012–2013. This report provides the current size of the marketing and advertising budgets of global pharmaceutical industry suppliers and how spending by global pharmaceutical industry suppliers will change, providing insight into global marketing behaviour. In addition, the report also identifies future growth of buyers and suppliers and M&A activity. This report not only grants access to the opinions and strategies of business decision makers and competitors, but also examines their actions surrounding business priorities. The report also provides access to information categorized by region, company type and sizes."

 

Key Highlights

 

Social media and networking sites', 'email and newsletters' and 'online content sites' to dominate future investment

Social media and networking sites', 'email and newsletters' and 'online content sites' are projected to record the strongest investment, as identified by 56%, 54%, 53% of respective respondents. This indicates that marketers are expected to allocate a higher proportion of budget towards new media such as emails, internet searches and websites.

 

'Customer retention', 'customer acquisition' and 'brand building or awareness' dominates key marketing aim of suppliers for 2012–2013

'Customer retention', 'customer acquisition' and 'brand building or awareness' are identified as key marketing aims for global pharmaceutical industry suppliers, with 63%, 48% and 41% of industry respondents expressing that these were very important aims. The most significant strategy that global pharmaceutical industry suppliers plan to employ in 2012 is to 'focus sales efforts on generating new business', as identified by 57% of respondents.

 

'Ability to target specific audience niches', 'ability to generate leads or setup customer meetings' and 'thorough reporting and analysis' are the three leading critical success factors for suppliers in 2012

In the process of choosing marketing agencies, the 'ability to target specific audience niches', 'ability to generate leads or setup customer meetings' and 'thorough reporting and analysis' are considered deciding factors by respondents from the global pharmaceutical supplier industry. Survey results indicate that critical success factors have not changed significantly since 2011.

 

Geographical variations

Of all respondents, 67% from companies that operate in the Rest of the World region are optimistic about revenue growth over the next 12 months, compared to 61% in the Asia-Pacific region, 56% in North America and 52% in Europe.

 

M&A Drivers

Need for new product pipelines, new product acquisition, patent expiries, cost containment and credit availability are considered as major drivers for increase in M&A activities.

 

Companies Mentioned

 

Sanofi Aventis, Gen-Probe Incorporated, Neumedicines, RxBio, Araim Pharmaceuticals of Ossining and Cellerant Therapeutics, Pfizer, Tibet Pharmaceuticals, Anhui Taihe Pharmaceutical Group, BioMarin Pharmaceutical, Abbott, Catalent Pharma Solutions, Vitamin Shoppe, OncoSec Medical, Quintiles, QPS, Neptune Technologies and Bioressources, Sartorius Stedim Biotech, Bosch Packaging Technology, Sanner, Bristol-Myers Squibb, Micromet, Amgen, OPKO Health USA, ALS Distribuidora Limitada, UCB Pharma, Astellas Pharma Inc, UCB Pharmaand Nodality, INC Research LLC, Trident Clinical Research, Accelrys, VelQuest, Indoco Remedies, DSM, Mylan Inc, Johnson & Johnson, J.B. Chemicals & Pharmaceuticals, Watson Pharmaceuticals, Ascent Pharmahealth, Strides Arcolab, Sigma-Aldrich, BioReliance, Takeda Pharmaceutical Company Ltd, Teva Pharmaceuticals, Sinopharm, Yunnan Baiyao Group Co Ltd, Zhangzhou Pientzehuang Pharmaceutical Co Ltd, Jiangsu Hengruli Medicine Co Ltd, Celesio, Bergamo, Ranbaxy Labs, Daiichi Sankyo, Matrix Lab, Dabur Pharma, Fresenius Kabi, Shanta Biotech, Orchid Chemicals, Hospira, Piramal Healthcare, Wuxi PharmaTech, AstraZenecahas, SOTAX, Baxter, GlaxoSmithKline, Lonza, Roche, ASAN Medical Center, Anosmatic Corporation, Chesapeake Pharmaceutical and Healthcare Packaging, Orkut, Twitter, Facebook, LinkedIn, PatientsLikeMe, DailyStrength, Google, Yahoo, Bing, Allergan Inc, MySpace, YouTube, Flickr.

 

 

 

Table of Contents

1 Introduction

1.1 What is This Report About?

1.2 Definitions

1.3 Methodology

1.4 Profile of Survey Respondents: Global Pharmaceutical Industry

1.4.1 Profile of buyer respondents: global pharmaceutical industry

1.4.2 Profile of supplier respondents: global pharmaceutical industry

2 Executive Summary

3 Global Pharmaceutical Industry Dynamics

3.1 Revenue Growth Expectations in the Global Pharmaceutical Industry

3.1.1 Global pharmaceutical industry: revenue growth expectations by company type

3.1.2 Global pharmaceutical industry: revenue growth expectations by region

3.1.3 Global pharmaceutical industry: revenue growth expectations by turnover

3.1.4 Global pharmaceutical industry: revenue growth expectations by senior level respondents

3.1.5 Global pharmaceutical industry: Revenue growth expectations-cross industry comparisons

3.2 Future Developments in Business Structure: Global Pharmaceutical Industry

3.2.1 Global pharmaceutical industry: future developments by buyers

3.2.2 Global pharmaceutical industry: future developments by suppliers

3.2.3 Global pharmaceutical industry: future developments by region

3.2.4 Global pharmaceutical industry: future developments by company turnover

3.3 M&A Activity Projections in the Global Pharmaceutical Industry

3.3.1 M&A activity projections in the global pharmaceutical industry by buyers

3.3.2 M&A activity projections in the global pharmaceutical industry by suppliers

3.3.3 M&A activity projections in the global pharmaceutical industry by region

3.3.4 M&A activity projections in the global pharmaceutical industry by company turnover

3.3.5 Global pharmaceutical industry: expansion abroad vs M&A activity projections

3.4 Capital Expenditure Forecast in the Global Pharmaceutical Industry

3.4.1 Capital expenditure forecast in the global pharmaceutical industry by buyers

3.4.2 Capital expenditure forecast in the global pharmaceutical industry by suppliers

3.4.3 Capital expenditure forecast in the global pharmaceutical industry by region

3.4.4 Capital expenditure forecast in the global pharmaceutical industry by company turnover

3.5 Planned Change in Staff Recruitment Activity: Global Pharmaceutical Industry

3.5.1 Global pharmaceutical industry: planned change in staff recruitment activity by buyers

3.5.2 Global pharmaceutical industry: planned change in staff recruitment activity by suppliers

3.5.3 Global pharmaceutical industry: planned change in staff recruitment activity by region

3.5.4 Global pharmaceutical industry: planned change in staff recruitment activity by company turnover

4 Global Pharmaceutical Industry Market Growth Outlook

4.1 Global Pharmaceutical Industry: Demand in Emerging Markets

4.1.1 Global pharmaceutical industry: demand in emerging markets by buyers

4.1.2 Global pharmaceutical industry: demand in emerging markets by suppliers

4.1.3 Global pharmaceutical industry: demand in emerging markets by region

4.1.4 Global pharmaceutical industry: demand in emerging markets by company turnover

4.2 Global Pharmaceutical Industry: Growth Expectations in Developed Countries

4.2.1 Global pharmaceutical industry: growth expectations in developed countries by buyers

4.2.2 Global pharmaceutical industry: growth expectations in developed countries by suppliers

4.2.3 Global pharmaceutical industry: growth expectations in developed countries by region

4.2.4 Global pharmaceutical industry: growth expectations in developed countries by company turnover

5 Threats and Opportunities for the Global Pharmaceutical Industry

5.1 Global Pharmaceutical Industry: Leading Business Concerns for 2012–2013

5.1.1 Global pharmaceutical industry: leading business concerns for 2012–2013 by company type

5.1.2 Global pharmaceutical industry: leading business concerns for 2012–2013 by region

5.1.3 Global pharmaceutical industry: leading business concerns for 2012–2013 by company turnover

5.2 Global Pharmaceutical Industry: Key Supplier Actions to Secure Buyer Business

5.2.1 Global pharmaceutical industry: key actions to secure buyer business (buyer respondents)

5.2.2 Global pharmaceutical industry: key actions to secure buyer business by region

5.2.3 Global pharmaceutical industry: key actions to secure buyer business by turnover

5.2.4 Global pharmaceutical industry: key actions to secure buyer business by procurement budget

5.2.5 Global pharmaceutical industry: key actions to secure buyer business by purchasing decision authority

6 Pharmaceutical Industry Supplier Marketing Spend Activity

6.1 Annual Marketing Budgets: Global Pharmaceutical Industry Suppliers

6.1.1 Annual marketing budgets by region: global pharmaceutical industry suppliers

6.1.2 Annual marketing budgets by company turnover: global pharmaceutical industry suppliers

6.2 Planned Change in Marketing Expenditure Levels: Global Pharmaceutical Industry Suppliers

6.2.1 Planned change in marketing expenditure by region: global pharmaceutical industry suppliers

6.2.2 Planned change in marketing expenditure by turnover: global pharmaceutical industry suppliers

6.2.3 Planned change in marketing expenditure levels vs. revenue growth expectations (%), 2012

6.3 Future Investment by Media Channel: Global Pharmaceutical Industry Suppliers

6.3.1 Future investment by media channel by region: global pharmaceutical industry suppliers

6.3.2 Future investment by media channel by company turnover: global pharmaceutical industry suppliers

6.4 Global Pharmaceutical Industry Suppliers' Future Investment in Marketing and Sales

6.4.1 Investment in marketing and sales by region: global pharmaceutical industry suppliers

6.4.2 Investment in marketing and sales by region: global pharmaceutical industry suppliers

6.4.3 Investment in marketing and sales by turnover: global pharmaceutical industry suppliers

7 Marketing and Sales Behaviors and Strategies in 2012-2013

7.1 Key Marketing Aims for 2012–2013: Global Pharmaceutical Industry Suppliers

7.1.1 Key marketing aims by region: global pharmaceutical industry suppliers

7.1.2 Key marketing aims by company turnover: global pharmaceutical industry suppliers

7.1.3 Key marketing aims by revenue growth expectations: global pharmaceutical industry suppliers

7.2 Essential Amendments to Marketing Activities in 2012–2013

7.2.1 Amendments to marketing activities by region: global pharmaceutical industry suppliers

7.2.2 Amendments to marketing activities by company turnover: global pharmaceutical industry suppliers

7.3 Use of New Media for Business Prospects: Global Pharmaceutical Industry Suppliers

7.3.1 Use of new media by region: global pharmaceutical industry suppliers

7.3.2 Use of new media by company turnover: global pharmaceutical industry suppliers

7.4 Critical Success Factors for Choosing a Marketing Agency

7.4.1 Critical success factors for choosing a marketing agency by region

7.4.2 Critical success factors for choosing a marketing agency by company turnover: global pharmaceutical industry suppliers

8 Appendix

8.1 Global Pharmaceutical Industry Survey Results – Closed Questions

8.2 Methodology

8.3 Contact us

8.4 About ICD Research

8.5 Disclaimer

 

 

List of Tables

Table 1: Total Global Pharmaceutical Industry Survey Respondents by Company Type, 2012

Table 2: Global Pharmaceutical Industry Buyer Respondents by Job Role (%), 2012

Table 3: Global Pharmaceutical Industry Buyer Respondents by Company Turnover (%), 2012

Table 4: Global Pharmaceutical Industry Buyer Respondents by Region (%), 2012

Table 5: Global Pharmaceutical Industry Supplier Respondents by Job Role (%), 2012

Table 6: Global Pharmaceutical Industry Supplier Respondents by Company Turnover (%), 2012

Table 7: Global Pharmaceutical Industry Supplier Respondents by Region (%), 2012

Table 8: Global Pharmaceutical Industry Revenue Growth Optimism (%), 2010–2012

Table 9: Global Pharmaceutical Industry Revenue Growth Optimism by Buyers (%), 2010–2012

Table 10: Global Pharmaceutical Industry Revenue Growth Optimism by Region (%), 2010–2012

Table 11: Global Pharmaceutical Industry Revenue Growth Optimism by Turnover (%), 2012

Table 12: Global Pharmaceutical Industry Revenue Growth Optimism by Senior Level (%), 2012

Table 13: Key Changes In Business Structure: Global Pharmaceutical Manufacturers (%), 2012

Table 14: Key Changes In Business Structure: Global CRO and CMO (%), 2012

Table 15: Key Changes In Business Structure: Global Pharmaceutical Industry Supplier (%), 2012

Table 16: Global Pharmaceutical Industry: Future Developments by Region (%), 2012

Table 17: Global Pharmaceutical Industry: Future Developments by Turnover (%), 2012

Table 18: M&A Projections: Global Pharmaceutical Manufacturers(%), 2010–2012

Table 19: M&A Projections: Global CRO and CMO (%), 2010–2012

Table 20: M&A Projections: Global Pharmaceutical Industry Suppliers (%), 2010–2012

Table 21: Global Pharmaceutical Industry M&A Projections by Region (%), 2012

Table 22: Global Pharmaceutical Industry M&A Projections by Turnover (%), 2012

Table 23: Global Pharmaceutical Industry: Expand Abroad vs M&A Activity Projections (%), 2012

Table 24: Capital Expenditure Forecast by Global Pharmaceutical Manufacturers (%), 2012

Table 25: Capital Expenditure Forecast by Global CRO and CMO (%), 2012

Table 26: Capital Expenditure Forecast by Global Pharmaceutical Industry Supplier (%), 2012

Table 27: Staff Recruitment by Global Pharmaceutical Industry Buyers (%), 2012

Table 28: Staff Recruitment by Global Pharmaceutical Industry Suppliers (%), 2012

Table 29: Global Pharmaceutical Industry Staff Recruitment by Region (%), 2012

Table 30: Global Pharmaceutical Industry Staff Recruitment by Turnover (%), 2012

Table 31: Demand in Emerging Markets by Global Pharmaceutical Manufacturers (%), 2012

Table 32: Demand in Emerging Markets by Global CRO and CMO Industry (%), 2012

Table 33: Demand in Emerging Markets by Global Pharmaceutical Industry Suppliers (%), 2012

Table 34: Growth in Developed Countries: Global Pharmaceutical Manufacturers (%), 2012

Table 35: Growth Expectations in Developed Countries by Global CRO and CMO Respondents(%), 2012

Table 36: Growth Expectations in Developed Countries by Global Pharmaceutical Industry Suppliers (%), 2012

Table 37: Global Pharmaceutical Industry: Leading Concerns (%), 2010–2012

Table 38: Global Pharmaceutical Industry: Leading Business Concerns by Company (%), 2012–2013

Table 39: Global Pharmaceutical Industry: Leading Business Concerns by Region (%), 2012–2013

Table 40: Global Pharmaceutical Industry: Leading Business Concerns by Turnover (%), 2012–2013

Table 41: Actions to Maintain and Secure Buyer Business - Buyer vs. Supplier Responses (%), 2012

Table 42: Actions to Maintain and Secure Buyer Business - Buyer Responses (%), 2012

Table 43: Actions to Maintain and Secure Buyer Business by Region (%), 2012

Table 44: Actions to Maintain and Secure Buyer Business by Company Turnover (%), 2012

Table 45: Actions to Maintain and Secure Buyer Business by Procurement Budget (%), 2012

Table 46: Annual Marketing Budgets: Global Pharmaceutical Industry Suppliers (%), 2010–2012

Table 47: Annual Marketing Budgets by Region: Global Pharmaceutical Industry Suppliers (%), 2012

Table 48: Annual Marketing Budgets by Turnover: Global Pharmaceutical Industry Suppliers (%), 2012

Table 49: Planned Change in Marketing Expenditure: Global Pharmaceutical Suppliers (%), 2010–2012

Table 50: Planned Change in Marketing Expenditure Levels by Region (%), 2012

Table 51: Planned Change in Marketing Expenditure Levels by Company Turnover (%), 2012

Table 52: Change in Marketing Expenditure Levels by Revenue Growth Expectations (%), 2012

Table 53: Net Change in Planned Marketing Expenditure, All Industries Comparison (%) 2012

Table 54: Future Investment by Media Channels : Global Pharmaceutical Industry Suppliers (%), 2012

Table 55: Investment in Marketing and Sales: Global Pharmaceutical Industry Suppliers (%) , 2012

Table 56: Investment in Marketing and Sales by Region: Global Pharmaceutical Industry Suppliers (%) , 2012

Table 57: Investment in Marketing and Sales by Turnover: Global Pharmaceutical Industry Suppliers (%) , 2012

Table 58: Key Marketing Aims: Global Pharmaceutical Industry Suppliers (%), 2012

Table 59: Amendments to Marketing Activities: Global Pharmaceutical Industry Suppliers (%) , 2012

Table 60: Amendments to Marketing by Region: Global Pharmaceutical Industry Suppliers (%) , 2012

Table 61: Amendments to Marketing by Turnover: Global Pharmaceutical Industry Suppliers (%) , 2012

Table 62: Use of New Media by Suppliers: Global Pharmaceutical Industry (%),2012

Table 63: Use of New Media by Region: Global Pharmaceutical Industry (%),2012

Table 64: Use of New Media by Company Turnover: Global Pharmaceutical Industry (%),2012

Table 65: Critical Success Factors: Global Pharmaceutical Industry Suppliers (%), 2010–2012

Table 66: Critical Success Factors by Region: Global Pharmaceutical Industry Suppliers (%), 2012

Table 67: Critical Success Factors by Turnover: Global Pharmaceutical Industry Suppliers (%), 2012

Table 68: Survey Results - Closed Questions

 

 

List of Figures

Figure 1: Global Pharmaceutical Industry Revenue Growth Optimism (%), 2010–2012

Figure 2: Global Pharmaceutical Industry Revenue Growth Optimism by Company Type(%), 2010–2012

Figure 3: Global Pharmaceutical Industry Revenue Growth Optimism by Region (%), 2010–2012

Figure 4: Global Pharmaceutical Industry Revenue Growth Optimism by Turnover (%), 2012

Figure 5: Global Pharmaceutical Industry Revenue Growth Optimism by Senior Level (%), 2012

Figure 6: Revenue Growth Optimism: Cross Industry Comparison (%), 2012

Figure 7: Key Changes In Business Structure: Global Pharmaceutical Manufacturers (%), 2012

Figure 8: Key Changes In Business Structure: Global CRO and CMO (%), 2012

Figure 9: Key Changes In Business Structure: Global Pharmaceutical Industry Supplier (%), 2012

Figure 10: Global Pharmaceutical Industry: Future Developments by Region (%), 2012

Figure 11: Global Pharmaceutical Industry: Future Developments by Turnover (%), 2012

Figure 12: M&A Projections: Global Pharmaceutical Manufacturers(%), 2010–2012

Figure 13: M&A Projections: Global CRO and CMO Industry (%), 2010–2012

Figure 14: M&A Projections: Global Pharmaceutical Industry Suppliers (%), 2010–2012

Figure 15: Global Pharmaceutical Industry M&A Projections by Region (%), 2012

Figure 16: Global Pharmaceutical Industry M&A Projections by Turnover (%), 2012

Figure 17: Global Pharmaceutical Industry: Expand Abroad vs M&A Activity Projections (%), 2012

Figure 18: Capital Expenditure Forecast by Global Pharmaceutical Manufacturers (%), 2012

Figure 19: Capital Expenditure Forecast by Global CRO and CMO (%), 2012

Figure 20: Capital Expenditure Forecast by Global Pharmaceutical Industry Supplier (%), 2012

Figure 21: Global Pharmaceutical Industry Capital Expenditure Forecast by Region (%), 2012

Figure 22: Global Pharmaceutical Industry Capital Expenditure Forecast by Turnover (%), 2012

Figure 23: Staff Recruitment by Global Pharmaceutical Industry Buyers (%), 2012

Figure 24: Planned Change in Staff Hiring Activities by Pharmaceutical Industry Suppliers (%), 2012

Figure 25: Global Pharmaceutical Industry Staff Recruitment by Region (%), 2012

Figure 26: Planned Change in Staff Hiring Activities by Company Turnover (%), 2012

Figure 27: Global Pharmaceutical Industry: Top Ten Growth Regions (%), 2012

Figure 28: Global Pharmaceutical Industry: Top Five Emerging Markets, 2012

Figure 29: Demand in Emerging Markets by Global Pharmaceutical Manufacturers (%), 2012

Figure 30: Demand in Emerging Markets by Global CRO and CMO Industry (%), 2012

Figure 31: Demand in Emerging Markets by Global Pharmaceutical Industry Suppliers (%), 2012

Figure 32: Global Pharmaceutical Industry: Demand in Emerging Markets by Region (%), 2012

Figure 33: Global Pharmaceutical Industry: Demand in Emerging Markets by Turnover (%), 2012

Figure 34: Global Pharmaceutical Industry: Top Five Developed Countries Targeted for Growth, 2012

Figure 35: Growth in Developed Countries: Global Pharmaceutical Manufacturers (%), 2012

Figure 36: Growth Expectations in Developed Countries by Global CRO and CMO Respondents(%), 2012

Figure 37: Growth Expectations in Developed Countries by Global Pharmaceutical Industry Suppliers (%), 2012

Figure 38: Global Pharmaceutical Industry: Growth in Developed Countries by Region (%), 2012

Figure 39: Global Pharmaceutical Industry: Growth Expectations in Developed Countries by Turnover (% 'Increase' Responses), 2012

Figure 40: Global Pharmaceutical Industry: Leading Business Concerns (%), 2012–2013

Figure 41: Global Pharmaceutical Industry: Leading Business Concerns (%), 2012–2013

Figure 42: Global Pharmaceutical Industry: Leading Business Concerns by Company (%), 2012–2013

Figure 43: Actions to Maintain and Secure Buyer Business - Buyer vs. Supplier Responses (%), 2012

Figure 44: Actions to Maintain and Secure Buyer Business - Buyer Responses (%), 2012

Figure 45: Actions to Maintain and Secure Buyer Business by Company Region (%), 2012

Figure 46: Actions to Maintain and Secure Buyer Business by Company Turnover (%), 2012

Figure 47: Actions to Maintain and Secure Buyer Business by Purchasing Decision Authority (%), 2012

Figure 48: Annual Marketing Budgets: Global Pharmaceutical Industry Suppliers (%), 2010–2012

Figure 49: Annual Marketing Budgets by Region: Global Pharmaceutical Industry Suppliers (%), 2012

Figure 50: Annual Marketing Budgets by Turnover: Global Pharmaceutical Industry Suppliers (%), 2012

Figure 51: Planned Change in Marketing Expenditure: Global Pharmaceutical Suppliers (%), 2010–2012

Figure 52: Planned Change in Marketing Expenditure Levels by Region (%), 2012

Figure 53: Planned Change in Marketing Expenditure Levels by Company Turnover (%), 2012

Figure 54: Future Investment by Media Channels : Global Pharmaceutical Industry Suppliers (%), 2012

Figure 55: Global Pharmaceutical Industry Suppliers: Investment in Media Channels by Region (%), 2012

Figure 56: Global Pharmaceutical Industry Suppliers: Investment in Media Channels by Turnover (%), 2012

Figure 57: Investment in Marketing and Sales: Global Pharmaceutical Industry Suppliers (%), 2012

Figure 58: Investment in Marketing and Sales by Region: Global Pharmaceutical Industry Suppliers (%), 2012

Figure 59: Investment in Marketing and Sales by Turnover: Global Pharmaceutical Industry Suppliers (%), 2012

Figure 60: Key Marketing Aims: Global Pharmaceutical Industry Suppliers (%), 2012

Figure 61: Key Marketing Aims by Region: Global Pharmaceutical Industry Suppliers (%), 2012

Figure 62: Key Marketing Aims by Turnover: Global Pharmaceutical Industry Suppliers (%), 2012

Figure 63: Key Marketing Aims by Revenue Growth Expectations: Global Pharmaceutical Industry Suppliers (%), 2012

Figure 64: Amendments to Marketing Activities: Global Pharmaceutical Industry Suppliers (%) , 2012

Figure 65: Amendments to Marketing by Region: Global Pharmaceutical Industry Suppliers (%) , 2012

Figure 66: Amendments to Marketing by Turnover: Global Pharmaceutical Industry Suppliers (%) , 2012

Figure 67: Use of New Media by Suppliers: Global Pharmaceutical Industry (%), 2012

Figure 68: Use of New Media by Region: Global Pharmaceutical Industry (%), 2012

Figure 69: Use of New Media by Company Turnover: Global Pharmaceutical Industry (%), 2012

Figure 70: Critical Success Factors: Global Pharmaceutical Industry Suppliers (%), 2012

Figure 71: Critical Success Factors by Region: Global Pharmaceutical Industry Suppliers (%), 2012

Figure 72: Critical Success Factors by Turnover: Global Pharmaceutical Industry Suppliers (%), 2012

 

 

 

To order this report:

Marketing Industry: Global Pharmaceutical Survey 2012–2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry

 

 

More Market Research Report

 

 

 

Check our Industry Analysis and Insights

 

Nicolas Bombourg
Reportlinker
Email: nicolasbombourg@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved


Related medicine technology :

1. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
2. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
3. Directors Forum: PEPFAR and the Global AIDS Response
4. Alfacell Corporation to Present at UBS Global Life Sciences Conference
5. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
6. Global HIV Vaccine Enterprise Names Alan Bernstein as Inaugural Executive Director, Opens New Secretariat
7. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
8. Hillary Clinton Pledges Bold Approach to Stopping HIV/AIDS & Global Poverty
9. IBA and Elekta Initiate Global Particle Therapy Program at ASTRO
10. Dr. Rajeev Venkayya Joins Gates Foundation as Director of Global Health Delivery
11. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... 2016 Amgen (NASDAQ: AMGN ) will present ... Conference at 9:15 a.m. ET on Wednesday, Feb. 10, 2016, ... W. Meline , executive vice president and chief financial officer ... the presentation can be accessed from the Events Calendar on ... the webcast will also be available on Amgen,s website for ...
(Date:2/5/2016)... 2016  Patients in Alabama seeking ... therapy no longer have to travel out of state. ... Urology Centers of Alabama to provide a total ... qualifying patients. Alabama is ... of prostate cancer using many different modalities. They are the ...
(Date:2/5/2016)... York , February 5, 2016 ... Transparency Market Research report states that the global active ... 2014 and is predicted to reach US$185.9 bn by ... of 6.50% from 2014 to 2020. The title of ... Chemical/Biological, Captive/Contract Manufactured, by Geography, and by Therapeutic Area) ...
Breaking Medicine Technology:
(Date:2/5/2016)... ... 2016 , ... US Sports Camps , official operators of Nike Yoga ... kids yoga training. ChildLight Yoga Studio is centrally situated in the picturesque New England ... Yoga Studio founder Lisa Flynn expresses her excitement, “We are thrilled to be partnering ...
(Date:2/5/2016)... ... 2016 , ... The American public tends to feel uncomfortable about drinking recycled ... municipal or well water. The recent experience with lead contaminated water in Flint, Michigan, ... way toward increasing public acceptance of recycled waste water as drinking water. , ...
(Date:2/5/2016)... ... February 05, 2016 , ... Give To Cure today announced that ... donate to Give To Cure’s campaign that is crowdfunding clinical trials to help find ... share payments through a smart device. In 2015 alone, Venmo processed $7.5 billion in ...
(Date:2/5/2016)... ... 2016 , ... Pivot Point Consulting, a leading national Healthcare ... Services for HIT Implementation Support & Staffing report with an outstanding score of ... healthcare executives, managers and clinicians representing over 4,500 hospitals and 2,500 clinics. , ...
(Date:2/5/2016)... ... , ... Dr. Justin Scott and Dr. Lydia Muccioli of Pure Dental ... individuals in need. The event is scheduled to take place on February 27, 2016 ... provide dental care to community members in need. Each patient will be given the ...
Breaking Medicine News(10 mins):